Real‐world use of lecanemab: patient pathway findings from a US multicenter study
Fuente:
Wiley Open Access
Enregistré dans:
| Auteurs principaux: | Michael Rosenbloom, Courtney Adams, Brooke Allen, Brent Berry, Christian Camargo, Gregory Cooper, Samuel Giles, Cara Leahy, Marwan Sabbagh, Martin Sadowski, Curtis Schreiber, Paul E. Schulz, Jose Soria, David Weisman, Feride Frech, Daryl Rhys Jones |
|---|---|
| Format: | Artículo Open Access |
| Publié: |
Wiley
2026
|
| Sujets: | |
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
Real‐World Insights on the Lecanemab Patient Pathway in Early Alzheimer’s Disease in the United States
par: Michael Henry Rosenbloom, et autres
Publié: (2025)
par: Michael Henry Rosenbloom, et autres
Publié: (2025)
Blood‐Based Biomarkers in the Lecanemab Patient Pathway for Early Alzheimer’s Disease in the United States
par: Cara Leahy, et autres
Publié: (2025)
par: Cara Leahy, et autres
Publié: (2025)
Real‐World Use of Lecanemab in APOE ε4 Homozygotes and in Patients on Antithrombotic Therapy
par: Marwan N. Sabbagh, et autres
Publié: (2025)
par: Marwan N. Sabbagh, et autres
Publié: (2025)
Real‐World Use of Lecanemab in Patients With Early Alzheimer’s Disease in the United States: a Case Series Review
par: David C Weisman, et autres
Publié: (2025)
par: David C Weisman, et autres
Publié: (2025)
Real‐world experience with lecanemab therapy for Alzheimer's disease in the Intermountain West
par: Bethany C. Curd, et autres
Publié: (2026)
par: Bethany C. Curd, et autres
Publié: (2026)
Perspectives on Fetal Sex and Prenatal Diagnosis of Differences of Sex Development Among Midwives
par: Madeline Dingle, et autres
Publié: (2025)
par: Madeline Dingle, et autres
Publié: (2025)
Real‐world use of diagnostic tests for mild cognitive impairment, Alzheimer's disease, and other dementias in Medicare fee‐for‐service beneficiaries
par: Jessie T. Yan, et autres
Publié: (2025)
par: Jessie T. Yan, et autres
Publié: (2025)
Initial real‐world experience with lecanemab prescribing patterns in Japan: The Longevity Improvement & Fair Evidence (LIFE) Study
par: Kengo Kawaguchi, et autres
Publié: (2026)
par: Kengo Kawaguchi, et autres
Publié: (2026)
Prenatal cardiac findings and 22q11.2 deletion syndrome: Fetal detection and evaluation
par: Elizabeth Goldmuntz, et autres
Publié: (2024)
par: Elizabeth Goldmuntz, et autres
Publié: (2024)
Raine syndrome: Prenatally identified severe craniofacial phenotype with multisuture synostosis and brain abnormalities associated with variants in FAM20C
par: Courtney P. Verscaj, et autres
Publié: (2024)
par: Courtney P. Verscaj, et autres
Publié: (2024)
Telegenetics to provide comprehensive prenatal diagnosis
par: April D. Adams, et autres
Publié: (2024)
par: April D. Adams, et autres
Publié: (2024)
Prenatal diagnosis of ROR‐2 related Robinow syndrome presenting with fetal ultrasound findings of mesomelia, vertebral, digital and genital abnormalities
par: Liying Yang, et autres
Publié: (2024)
par: Liying Yang, et autres
Publié: (2024)
Sex Ratios at Birth Following Non‐Invasive Prenatal Testing in Victoria, Australia
par: Hilary Bowman‐Smart, et autres
Publié: (2026)
par: Hilary Bowman‐Smart, et autres
Publié: (2026)
Clinical Characteristics and Outcomes of Intrauterine Blood Transfusion (IUT) for Infectious Etiologies
par: Jessian L. Munoz, et autres
Publié: (2024)
par: Jessian L. Munoz, et autres
Publié: (2024)
Theoretical Performance of Comprehensive Non‐Invasive Prenatal Screening in Congenital Heart Defects
par: Emily Yang, et autres
Publié: (2026)
par: Emily Yang, et autres
Publié: (2026)
Risk prediction of mild cognitive impairment using electronic health record data
par: Gang Li, et autres
Publié: (2025)
par: Gang Li, et autres
Publié: (2025)
High positive predictive value 22q11.2 microdeletion screening by prenatal cell‐free DNA testing that incorporates fetal fraction amplification
par: Carly Hammer, et autres
Publié: (2024)
par: Carly Hammer, et autres
Publié: (2024)
Severe Early‐Onset Fetal Growth Restriction: The Yield of Antenatal and Postnatal Genetic Testing
par: Matthew H. Mossayebi, et autres
Publié: (2026)
par: Matthew H. Mossayebi, et autres
Publié: (2026)
Risk of Genetic Abnormality in Fetuses With Unilateral Versus Bilateral Pleural Effusions
par: Brian Burnett, et autres
Publié: (2024)
par: Brian Burnett, et autres
Publié: (2024)
Dengue fever as a cause of hemophagocytic lymphohistiocytosis
par: Noely Hein
Publié: (2015)
par: Noely Hein
Publié: (2015)
Screening tools for oropharyngeal dysphagia in stroke
par: Tatiana Magalhães de Almeida
Publié: (2015)
par: Tatiana Magalhães de Almeida
Publié: (2015)
Autopsy findings of acute erythroid leukemia
par: Mayur Parkhi
Publié: (2023)
par: Mayur Parkhi
Publié: (2023)
Diagnostic Yield of Exome Sequencing for Pregnancies With and Without Fetal Anomalies and for Stillbirth
par: Roni Zemet, et autres
Publié: (2025)
par: Roni Zemet, et autres
Publié: (2025)
P‐tau217 testing impact on intended management of patients presenting with cognitive impairment: A randomized clinical utility study
par: Samantha C. Burnham, et autres
Publié: (2025)
par: Samantha C. Burnham, et autres
Publié: (2025)
Navigating late‐stage dementia: A perspective from the Alzheimer's Association
par: Kristen Clifford, et autres
Publié: (2024)
par: Kristen Clifford, et autres
Publié: (2024)
Establishment and verification of reference intervals for Alzheimer's disease plasma biomarkers based on evaluation of pre‐analytical procedures: a multicenter study
par: Wencan Jiang, et autres
Publié: (2025)
par: Wencan Jiang, et autres
Publié: (2025)
Acoustic speech features are associated with late‐life depression and apathy symptoms: Preliminary findings
par: Daniel Harlev, et autres
Publié: (2025)
par: Daniel Harlev, et autres
Publié: (2025)
Criterion and convergent validity of plasma biomarkers in early‐onset Alzheimer's disease: Initial findings from LEADS
par: Dustin B. Hammers, et autres
Publié: (2026)
par: Dustin B. Hammers, et autres
Publié: (2026)
Spinal Muscular Atrophy Carrier Screening: Assessment of Provider Knowledge and Clinical Practice
par: Melissa Riegel, et autres
Publié: (2025)
par: Melissa Riegel, et autres
Publié: (2025)
Has the introduction of increased genetic prenatal testing affected rates of termination of pregnancy due to fetal abnormality?
par: Line Raaby, et autres
Publié: (2024)
par: Line Raaby, et autres
Publié: (2024)
Transforming Prenatal Care in a Highly Inbred Population: Impact of a Multidisciplinary Board
par: Abdullah H. Alfalah, et autres
Publié: (2026)
par: Abdullah H. Alfalah, et autres
Publié: (2026)
Variation in the Genetic Workup of Polyhydramnios: An International and Inter‐Specialty Survey
par: Roni Zemet, et autres
Publié: (2026)
par: Roni Zemet, et autres
Publié: (2026)
Test performance and clinical utility of expanded non‐invasive prenatal test: Experience on 71,883 unselected routine cases from one single center
par: Monica Faieta, et autres
Publié: (2024)
par: Monica Faieta, et autres
Publié: (2024)
In‐Utero Therapy for Fetal Vascular Anomalies: Efficacy and Tolerance of Sirolimus Administered to the Pregnant Patient
par: Ionela Iacobas, et autres
Publié: (2025)
par: Ionela Iacobas, et autres
Publié: (2025)
Moderate Diagnostic Yield of Exome Sequencing in Fetal Growth Restriction: Retrospective Insights
par: Maud Langeois, et autres
Publié: (2026)
par: Maud Langeois, et autres
Publié: (2026)
Predictors of fetal death, neonatal survival and neurological outcomes in severe twin‐twin transfusion syndrome treated by laser ablation of placental vessels
par: Cleisson Fábio Andrioli Peralta, et autres
Publié: (2024)
par: Cleisson Fábio Andrioli Peralta, et autres
Publié: (2024)
Fetal Sylvian Fissure Maturation in Congenital Heart Disease and Its Relation to Expected Brain Arterial Oxygen Saturation: A Longitudinal Study
par: Xiaowei Xiong, et autres
Publié: (2026)
par: Xiaowei Xiong, et autres
Publié: (2026)
Prenatal Ultrasound Features of Biliary Atresia: Diagnostic Significance of Abnormal Gallbladder Size and Hepatic Hilar Cyst
par: Wu Xu, et autres
Publié: (2025)
par: Wu Xu, et autres
Publié: (2025)
Mammalian target of rapamycin inhibitors: A new‐possible approach for in‐utero medication therapy
par: Shohra Qaderi, et autres
Publié: (2024)
par: Shohra Qaderi, et autres
Publié: (2024)
Opportunities and Challenges of Fetal Gene Therapy
par: Médéric Jeanne, et autres
Publié: (2025)
par: Médéric Jeanne, et autres
Publié: (2025)
Documents similaires
-
Real‐World Insights on the Lecanemab Patient Pathway in Early Alzheimer’s Disease in the United States
par: Michael Henry Rosenbloom, et autres
Publié: (2025) -
Blood‐Based Biomarkers in the Lecanemab Patient Pathway for Early Alzheimer’s Disease in the United States
par: Cara Leahy, et autres
Publié: (2025) -
Real‐World Use of Lecanemab in APOE ε4 Homozygotes and in Patients on Antithrombotic Therapy
par: Marwan N. Sabbagh, et autres
Publié: (2025) -
Real‐World Use of Lecanemab in Patients With Early Alzheimer’s Disease in the United States: a Case Series Review
par: David C Weisman, et autres
Publié: (2025) -
Real‐world experience with lecanemab therapy for Alzheimer's disease in the Intermountain West
par: Bethany C. Curd, et autres
Publié: (2026)